| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
61,644
|
65,020
|
61,152
|
59,009
| | Cost of Revenue | 37,644 | 39,661 | 37,404 | 36,620 | | |
Gross Profit
|
24,000
|
25,359
|
23,748
|
22,389
| |
|
Operating Expenses |
|
Research Development | 5,108 | 4,690 | 4,274 | 4,250 |
|
Selling General and Administrative | 23,428 | 22,579 | 21,820 | 21,430 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(4,536)
|
(1,910)
|
(2,346)
|
(3,291)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (176) | (30) | 13 | (79) |
|
Earnings Before Interest And Taxes | (4,712) | (1,940) | (2,333) | (3,370) |
|
Interest Expense | 150 | 91 | 26 | 1,456 |
|
Income Before Tax | (4,862) | (2,031) | (2,359) | (4,826) |
|
Income Tax Expense | 132 | 333 | 223 | 237 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (4,994) | (2,364) | (2,582) | (5,063) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(4,994)
|
(2,364)
|
(2,582)
|
(5,063)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(4,994)
|
(2,364)
|
(2,582)
|
(5,063)
|
|
0.24(1.78%) 1:04PM EDT - Nasdaq Real Time Price